Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

UniQure pulls first EU gene therapy

Decision made due to lack of demand

How will capitated budgets affect NHS spending?

Sue Thomas and Paul Midgley, of Wilmington Healthcare, assess the implications of a single budget covering all the physical, mental and social care needs of patients in an STP

Wilmington Healthcare

- PMLiVE

Amgen sues Sanofi and Regeneron over eczema drug

Alleges patent infringement and seeks financial reparations

- PMLiVE

Lucid Group Achieve UK’s Highest Award for Business Success

Lucid Group have been chosen to receive a Queen’s Award for Enterprise in International Trade. This award is widely regarded as the UK’s highest accolade for business success and they...

Lucid Group Communications Limited

- PMLiVE

Brexit: Implications for the pharma industry

From patents to the EMA, data protection to clinical trials, there's a lot that should be a concern

- PMLiVE

AbbVie’s PARP inhibitor veliparib fails to deliver

Phase III trials show no increase in clinical benefit

- PMLiVE

Verily’s Baseline health project seeks 10,000 volunteers

Four-year study to produce a molecular snapshot

Roche Basel Switzerland

Roche claims another FDA green light for Tecentriq

Wins approval for the treatment's first-line use in bladder cancer

Can UK pharma rise to the post-Brexit challenge?

Our dominant and thriving industry is one we should be proud of

- PMLiVE

Ipsen appoints executive vice president

Alexandre Lebeaut also set to be chief scientific officer

Top tips for “digitally cautious” pharma

Some practical ways to enter this new era of customer and patient-centricity

- PMLiVE

Circassia exits allergy R&D after placebo effect strikes again

Abandons phase IIb trial of house dust mite allergy candidate

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links